Success of hypertension treatment depends on how well the chosen treatment mode matches the patient’s genotype. Specialists of the Chair of Balneology and Physical Therapy (Kirov Army Medical College) have determined how the hypertensive patient’s genotype impacts the efficiency of magnetic-laser therapy.
Primary hypertension is one of the most frequent diseases, the treatment of which is still a problem to contemporary medicine. The disease is determined by some genes, each of the genes may exist in several variants. Respective combination of these genes forms the so-called “risk threshold” of disease origin. The major contribution to the hypertension evolution is made by the genes of angiotensinogen (AGT), angiotensin converting enzyme (ACE) and some others. Their combination determines not only the risk of disease occurrence, but also a potential success of its treatment. Thus, adrenolytic drugs act differently on central hemodynamics depending on the AGT and ACE genes’ polymorphism. Besides drug therapy, there exist physical treatment modes, specifically - magnetic-laser therapy. The St. Petersburg physicians have researched how its effectiveness depends on genotype.
Magnetic-laser therapy effectiveness was evaluated with 101 patients with different variants of genes’ polymorphism. The polymorphism itself was determined with the help of the polymerase chain reaction, having taken some venous blood from the patients. Participants to the experiment underwent a radiation treatment course consisting of ten everyday sessions, the patients being examined before and after the course. Physicians watched the blood pressure changes within 24 hours and the reaction to physical activity (the patients were placed on the bicycle ergometer). Polymorphism of different genes determines the clinical behavior and treatment effectiveness to different extent. Magnetic-laser therapy helps the majority of hypertensive patients. The ACE gene has the highest influence on the magnetic-laser therapy results. In case of one variant of polymorphism (it is called MM- polymorphism) the blood pressure falls down to the greatest degree. The researchers have also found the combinations where the effect is the lowest (this is TT-polymorphism of the angiotensinogen gene). It is interesting to note that the variant of angiotensin converting enzyme (ACE) polymorphism is the worst for success of magnetic-laser therapy but it is optimal for drug treatment of high blood-pressure.
Sergey Komarov | alfa
NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases
Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
19.03.2018 | Physics and Astronomy
19.03.2018 | Materials Sciences
19.03.2018 | Event News